Anthogyr

Also known as: Anthogyr SAS, Axiom

A French implant brand based in Sallanches, wholly owned by the Straumann Group, whose main implant range is Axiom.

Key facts

Manufacturer	Straumann GroupVerified spec[1][2]
Parent company	Straumann Holding AGVerified spec[1]
Country	FranceVerified spec[2][1]
Headquarters	Sallanches, FranceVerified spec[2][1]
Founded	The company began manufacturing dental implants in 1980Verified spec[2]The wider Anthogyr business is older; we have not confirmed its original founding date from a primary source
Ownership	Anthogyr SAS is listed at 100% ownership in the Straumann Group’s statutory group-companies table. Straumann took an initial 30% stake in early 2016 and completed full ownership in 2019Verified spec[1][2]
Manufacturer-described indication	Product families centre on the Axiom implant platform, with bone-level, tissue-level and multi-unit prosthetic optionsManufacturer-reported[1]
manufacturingCountry	FranceVerified spec[3]Country of the FDA-registered device establishment, which may differ from the brand’s home country.

Overview

Anthogyr is a good illustration of how gradual implant-industry acquisitions are. Straumann bought 30% of the French manufacturer in early 2016, took over its business in China at the same time, and only completed full ownership in 2019 — so sources from any point in that window describe a different arrangement, all of them once accurate. The brand continues to be sold under its own name from Sallanches in the French Alps, with the Axiom platform as its main implant range. As with the group’s other brands, Anthogyr components are not interchangeable with Straumann-branded ones.

Regulatory record

Read this before drawing conclusions. A clearance or certificate means a device may legally be sold in a market. It is not a finding that the implant performs well, and it is not a comparison against other implants. In particular, FDA "clearance" is not FDA "approval" — clearance means the FDA accepted the device as substantially equivalent to one already on the market. What these actually mean →

FDA 510(k) clearance6 records

Cleared as substantially equivalent to a predicate device. Not an FDA approval, and not a finding of safety or effectiveness.

Number	Device	Holder	Date
K231072	Anthogyr FlexiBase® titanium bases for Axiom® BL	Anthogyr	2024-01-04
K230104	Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL	Anthogyr	2023-10-16
K161177	Axiom PX	Anthogyr Sas	2017-06-15
K141450	AXIOM 2.8	Anthogyr Sas	2014-09-17
K131066	AXIOM REG	Anthogyr Sas	2014-02-21
K101913	ANTHOFIT OI, ANTHOFIT HE, OSSFIT AND AXIOM	Anthogyr Sas	2011-03-11

Other2 records

Registered device establishment in France. Registration records where a device is made or handled; it is not a clearance, an approval, or any assessment of the product.

Number	Device	Holder	Date
8020776	—	ANTHOGYR	—
77 device records	—	Anthogyr	—

Clearance records for Anthogyr were retrieved from the issuing authority's own database, not from the manufacturer's marketing material. We attribute a clearance to a brand only when the filing holder belongs to that brand's corporate family — third-party clearances for compatible components are excluded, because they belong to the company that made the component, not to Anthogyr.

Sources

Numbers match the citations beside each claim above.

Primary sources

[1]Straumann Group Annual Report 2025 — Straumann Holding AG, 2026. Accessed 2026-07-21.
[2]Anthogyr joins the Straumann Group — Anthogyr SAS (distributed via GlobeNewswire), 2019. Accessed 2026-07-21.
[3]openFDA — Device registrations and listings — US Food and Drug Administration. Accessed 2026-07-22.